pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Marketed
olezarsen sodium
Tryngolza (olezarsen sodium)
Hypertriglyceridemia
$IONS
IONIS PHARMACEUTICALS INC
Marketed
olipudase alfa
Xenpozyme (olipudase alfa)
Niemann-Pick Disease Type B (Acid Sphingomyelinase Defici…
Genzyme Corp
Phase 2
olisutrigine bromide
olisutrigine bromide [INN]
Pruritus
Formation Bio Inc
Marketed
← prev
page 238 of 271
next →
Pain
89
Neurology
1
olmesartan medoxomil
Olmesartan Medoxomil
Hypertension
Umedica Laboratories Pvt Ltd
Marketed
olodaterol hydrochloride
Striverdi Respimat (olodaterol hydrochloride)
Chronic Bronchitis
Boehringer Ingelheim Corp
Phase 3
olomorasib
olomorasib
Non-Small Cell Lung Cancer
Eli Lilly and Co
Phase 3
olpasiran
olpasiran
Atherosclerosis
$AMGN
AMGEN INC
Marketed
olsalazine sodium
Dipentum (olsalazine sodium)
Ulcerative Colitis
Mylan Pharmaceuticals Inc
Marketed
olutasidenib
Rezlidhia (olutasidenib)
Refractory Acute Myeloid Leukemia
$RIGL
RIGEL PHARMACEUTICALS INC
Phase 3
olverembatinib
olverembatinib
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…
$AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
Phase 3
olvimulogene nanivacirepvec
olvimulogene nanivacirepvec
Endometrial Cancer
$GNLX
GENELUX Corp
Marketed
omacetaxine mepesuccinate
omacetaxine mepesuccinate
Myelodysplastic Syndrome (Preleukemia)
$TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Marketed
omadacycline tosylate
Nuzyra (omadacycline tosylate)
Mycobacterium Infections
Paratek Pharmaceuticals Inc
Marketed
omalizumab
Xolair (omalizumab)
Chronic Urticaria
Genentech Inc
Marketed
omaveloxolone
Skyclarys (omaveloxolone)
Friedreich Ataxia
Reata Pharmaceuticals Inc
Marketed
omega-3-acid ethyl esters
Omega-3-Acid Ethyl Esters Prasco (omega-3-acid ethyl esters)
Hypertriglyceridemia
Prasco LLC
Marketed
omeprazole XR-ODT
Omeprazole
Acid Indigestion (Heartburn/Pyrosis)
Dexcel Pharma Ltd
Marketed
omeprazole magnesium DR
Omeprazole Magnesium
Systemic Mastocytosis
Perrigo Pharmaceuticals Company (Inactive)
Marketed
omidenepag isopropyl
Omlonti (omidenepag isopropyl)
Ocular Hypertension
Ocuvex Therapeutics Inc
Phase 3
omidubicel
Omisirge (omidubicel-onlv)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…
Gamida Cell Ltd
Phase 2
omilancor
omilancor [INN]
Ulcerative Colitis
NImmune Biopharma Inc
Phase 2
ompenaclid succinate
ompenaclid succinate
Metastatic Colorectal Cancer
Inspirna Inc
Preclinical
onCARlytics
Triple-Negative Breast Cancer (TNBC)
Imugene Ltd
Marketed
onabotulinumtoxinA
Botox (onabotulinumtoxinA)
Lower Limb Muscle Spasticity
Allergan Sales LLC
Preclinical
onabotulinumtoxinA biosimilar
Blepharospasm
$VTRS
Viatris Inc
Marketed
onasemnogene abeparvovec
Itvisma (onasemnogene abeparvovec-xioi)
Spinal Muscular Atrophy (SMA)
Novartis Gene Therapies
Marketed
ondansetron hydrochloride ODT
Ondansetron (ondansetron hydrochloride)
Chemotherapy Induced Nausea and Vomiting
Sandoz Inc
Phase 3
onfekafusp alfa
onfekafusp alfa [INN]
Soft Tissue Sarcoma
Philogen SpA
Phase 2
onrogadgene parvec
onrogadgene parvec
Parkinson's Disease
$MGTX
MeiraGTx Holdings plc
Phase 2
ontunisertib
ontunisertib
Crohn's Disease (Regional Enteritis)
$AGMB
Agomab Therapeutics NV
